Merck, Sharp & Dohme LLC has submitted a proposal to the Foreign-Trade Zones Board for a production activity in their Rahway, New Jersey facility, which is part of Foreign-Trade Zone 49. The proposal outlines plans to manufacture various pharmaceutical products, including drugs for infectious and neurologic diseases, oncology, immunotherapy, and cardiovascular disease, using foreign materials. Some of these materials are subject to specific trade regulations depending on their country of origin. Public comments on the proposal are welcome until May 27, 2025, and those interested in more information can contact the Board or access documents on their website.
Simple Explanation
Merck, Sharp & Dohme LLC wants to make medicines in a special area in Rahway, New Jersey where they can get special rules to help them bring in parts from other countries. They're asking for comments from people to tell what they think about this idea until May 27, 2025.